(3-((2-Chlorobenzyl)oxy)phenyl)boronic acid

Catalog No. :
ACGBQZ924
CAS No. :
845551-45-3
Molecular Formula :
C13H12BClO3
Molecular Weight :
262.50

IUPAC Name:(3-((2-chlorobenzyl)oxy)phenyl)boronic acid

(3-((2-Chlorobenzyl)oxy)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$53.00Login to see priceInquiryInquiry
5g98%$192.00Login to see priceInquiryInquiry
25g98%$770.00Login to see priceInquiryInquiry
100g98%$2639.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-((2-Chlorobenzyl)oxy)phenyl)boronic acid
IUPAC Name(3-((2-chlorobenzyl)oxy)phenyl)boronic acid
MDL No.MFCD05865198
Molecular FormulaC13H12BClO3
Molecular Weight262.50
SMILESClC1=CC=CC=C1COC2=CC(B(O)O)=CC=C2
InChI KeyXHGOCNFADOJUMW-UHFFFAOYSA-N
Synonym3-[(2-chlorobenzyl)oxy]benzeneboronic acid;Boronic acid, B-[3-[(2-chlorophenyl)methoxy]phenyl]-;3-(2'-CHLOROBENZYLOXY)PHENYLBORONIC ACID
CAS No.845551-45-3
PubChem CID16217705

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGBQZ924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLDAW054 route compound structure diagram
    ACLDAW05487199-18-6 In Stock
  4. Then
  5. ACGBQZ924 route product structure diagram
    ACGBQZ924845551-45-3
Inquiry

2. ACGBQZ924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLDAW054 route compound structure diagram
    ACLDAW05487199-18-6 In Stock
  4. Then
  5. ACGBQZ924 route product structure diagram
    ACGBQZ924845551-45-3
Inquiry

Comments (0)